Mr Nikolaev was formerly Deputy Director of the Russian branch of the international law firm Clyde and Co. Prior to this he was at Rothman's International in St. Petersburg where he was an in-house lawyer and advised on the merger with British American Tobacco. Mr Nikolaev has also worked at Herbert Smith in London. His practice areas are corporate and commercial law, litigation and privatisation.
Dr Tatiana Zhuravskaya, a non-executive director at Lipoxen, is stepping down from the Board after six years but will remain with the Company as a consultant focusing on project management.
M. Scott Maguire, CEO of Lipoxen, said: "I am delighted to welcome Mr Nikolaev to the team and look forward to working with him in his new role as a Lipoxen board member. I regard this decision to join Lipoxen's Board as a great support to the Company's business and overall market opportunity. I, and the rest of the Board, look forward to the valuable contribution he will make to the Company. We would also like to thank Dr Zhuravskaya for her contributions to the Lipoxen board. Her technical expertise will continue to serve as valuable input on project managing and existing collaborations, as well as on our product candidate portfolio."
FORMAL DISCLOSURE
The Company makes the following formal disclosure in connection with the above-mentioned appointment:
Full name: Igor Anatolievich Nikolaev Age: 41
Current Directorships Appointed
Pharma Industries Ltd 17 May 2007
Pharma Research Ltd 17 May 2007
